Section Arrow
ZBH.NYSE
- Zimmer Biomet Holdings
Quotes are at least 15-min delayed:2026/11/20 17:54 EST
After Hours
Last
 102
+0.9 (+0.89%)
Bid
93.23
Ask
104.83
High 104.63 
Low 99.08 
Volume 71.63K 
Regular Hours (Closed)
Last
 101.1
-0.37 (-0.36%)
Day High 
103.865 
Prev. Close
101.47 
1-M High
112.545 
Volume 
2.96M 
Bid
93.23
Ask
104.83
Day Low
100.82 
Open
102.72 
1-M Low
94.03 
Market Cap 
19.20B 
Currency 美元 
P/E 25.62 
%Yield 0.95 
10-SMA 104.48 
20-SMA 101.83 
50-SMA 96.35 
52-W High 112.545 
52-W Low 79.12 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
3.96/8.98
Enterprise Value
26.14B
Balance Sheet
Book Value Per Share
67.19
Cash Flow
Cash Flow Yield
0.10
Income Statement
Total Revenue
8.23B
Operating Revenue Per Share
38.46
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp41.98-1.01-2.35%18.14PE
After Hours 42.3233 +0.3433 +0.82%
PACBPacific Biosciences of California1.63-0.13-7.39%-- 
After Hours 1.65 +0.02 +1.23%
MDTMedtronic plc99.94-0.67-0.67%24.78PE
After Hours 99.52 -0.42 -0.42%
QSIQuantum-Si0.909-0.161-15.05%-- 
After Hours 0.93 +0.021 +2.31%
ABTAbbott Laboratories103-0.87-0.84%38.76PE
After Hours 103.53 +0.53 +0.51%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The company has assembled a wide array of robotic platforms, and it spun out its dental and spine businesses in 2022.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.